KCNH2 and familial long QT syndrome: Reduced IKr from either off-target pharmacological block or loss-of-function KCNH2 variants causes the cardiac disorder long QT syndrome (LQTS) and increases the risk for cardiac arrhythmia, syncope, and sudden cardiac death (1, 2).